Our GLP-R peptide powder is third-party tested to ensure clarity, reliability, and integrity

Overview of GLP-R Peptide

LY3437943 (GLP-R) is a synthetic peptide investigated in preclinical research as a multi-receptor agonist with activity across glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. Due to this tri-agonist profile, GLP-R has become a subject of significant laboratory interest in studies examining metabolic signaling, energy balance pathways, and endocrine regulation mechanisms.

In controlled research environments, GLP-R is utilized to explore complex hormone signaling interactions and receptor crosstalk associated with metabolic homeostasis. Its molecular design enables researchers to investigate integrated incretin and glucagon pathway activity within experimental models.

GLP-R Research and Studies

Preclinical research involving LY3437943 (GLP-R) peptide has focused on its investigational role in metabolic pathway modulation and endocrine signaling. Laboratory studies have examined LY3437943 interactions with GLP-1, GIP, and glucagon receptors to better understand coordinated receptor activation and downstream signaling cascades.

Research models have explored LY3437943 relevance in studies related to glucose regulation, lipid metabolism, appetite signaling, and energy expenditure pathways. These findings are limited to non-clinical, controlled research settings and are intended solely to advance scientific understanding. No therapeutic or clinical claims are made or implied.

Research Studies

Published preclinical research has explored GLP-R's potential involvement in:

Multi-receptor endocrine signaling: Studies have examined simultaneous activation of GLP-1, GIP, and glucagon receptors in laboratory models.

Metabolic pathway research: Investigations have focused on glucose homeostasis, lipid utilization, and energy balance signaling.

Hormone receptor crosstalk: Research has evaluated coordinated incretin and glucagon receptor interactions.

Endocrine system modeling: LY3437943 has been studied as a tool for understanding complex peptide-mediated metabolic regulation.

Representative publications:

Jastreboff AM et al. “Triple–hormone receptor agonist retatrutide and metabolic regulation.” N Engl J Med. 2023.

Finan B et al. “Unimolecular multi-agonists for metabolic disease research.” Nat Med. 2015.

Campbell JE, Drucker DJ. “Pharmacology of incretin hormones.” Cell Metab. 2013.

Müller TD et al. “GLP-1, GIP, and glucagon receptor co-agonism.” Mol Metab. 2018.

GLP-R Specifications

Product: LY3437943 Peptide Powder

Quantity: 10mg, 20mg per vial

Appearance: White lyophilized powder

Purity: ≥98%, third-party tested

Storage: Store at −20°C. Protect from light.

CAS Number: 2381089-83-2

Buy GLP-R Online (Research Use Only)

Our GLP-R peptide powder is produced for laboratory research applications and undergoes independent third-party testing to confirm purity, stability, and analytical consistency. This peptide is supplied exclusively for scientific research and investigational use.

⚠️ Disclaimer: For laboratory research use only. Not for human consumption.